HemOnc Today 08.07.19 Research initiative aims to better understand link between immunotherapy, type 1 diabetes Read
Endpoints News 08.05.19 Close to a decade after Eli Lilly killed it, Jeffrey Bluestone’s ‘breakthrough’ drug is back and being steered to the FDA Read
Endpoints News 07.23.19 PACT Pharma says it’s perfected the tech to select neoantigens for personalized therapy — now onto the clinic Read
STAT 07.09.19 Billionaire Sean Parker is nerding out on cancer research. Science has never seen anyone quite like him Read
UCLA Jonsson Comprehensive Cancer Center 06.06.19 Researchers identify three-drug combination that helps curb the growth of deadly type of skin cancer Read
Daily Mail 05.29.19 Immunotherapy is fighting cancer but leaving 1% of patients with diabetes – and scientists ‘have no idea why’ Read
Philanthropy News Digest 05.29.19 Diabetes, Cancer Organizations Launch $10 Million Research Effort Read
Beyond Type 1 05.29.19 Groundbreaking Research Collaboration to Study Immunotherapy-Induced Diabetes Read